P004: Hydroxychloroquine for prevention of recurrent miscarriage: study protocol of an ongoing French multicenter randomized placebo-controlled trial

E. Pasquier (1) , L. de Saint Martin (1) , C. Chauleur (2) , C. Bohec , F. Bretelle (3) , V. Lejeune-Saada , J. Hannigsberg , C. Pimentel (4) , G. Plu-Bureau

1 DMIP - Brest - Département de Médecine Interne et Pneumologie [Brest]
2 GRT - Groupe de recherche sur la thrombose, pharmacologie des antithrombotiques et situations à risque
3 MEPHI - Microbes évolution phylogénie et infections
4 Centre for Environmental and Marine Studies (CESAM), Department of Environment and Planning, University of Aveiro

Domains: Life Sciences [q-bio]; Microbiology and Parasitology; Bacteriology; Life Sciences [q-bio]; Microbiology and Parasitology; Virology; Life Sciences [q-bio]; Microbiology and Parasitology; Parasitology; Life Sciences [q-bio]; Human health and pathology; Cardiology and cardiovascular system; Life Sciences [q-bio]; Human health and pathology; Emerging diseases; Life Sciences [q-bio]; Human health and pathology; Infectious diseases

E. Pasquier, L. de Saint Martin, C. Chauleur, C. Bohec, F. Bretelle, et al.. P004: Hydroxychloroquine for prevention of recurrent miscarriage: study protocol of an ongoing French multicenter randomized placebo-controlled trial. Thrombosis Research, 2019, 175, pp.S7-S8. ⟨10.1016/S0049-3848(19)30099-4⟩. ⟨hal-02444342⟩